Kurt A. Gustafson
2009 - Halozyme Therapeutics
Compensation breakdown
Non-Equity Incentive Plan | $4,918 |
---|---|
Option Awards | $681,920 |
Salary | $225,000 |
Other | $148,573 |
Total | $1,060,411 |
Gustafson received $681.9K in option awards, accounting for 64% of the total pay in 2009.
Gustafson also received $4.9K in non-equity incentive plan, $225K in salary and $148.6K in other compensation.
Rankings
In 2009, Kurt A. Gustafson's compensation ranked 4,264th out of 9,885 executives tracked by ExecPay. In other words, Gustafson earned more than 56.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,264 | 57th |
Manufacturing | 1,518 | 59th |
Chemicals And Allied Products | 289 | 67th |
Drugs | 175 | 73rd |
Biological Products, Except Diagnostic Substances | 30 | 77th |
Gustafson's colleagues
We found eight more compensation records of executives who worked with Kurt A. Gustafson at Halozyme Therapeutics in 2009.
2009
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2009
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2009
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2009
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2009
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2009
David Ramsay
Halozyme Therapeutics
Vice President Corporate Development
2009
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2009
Michael LaBarre
Halozyme Therapeutics
Vice President, Product Development
News
April 26, 2024
May 1, 2023
April 27, 2022
April 22, 2020
April 23, 2019